Safety and efficacy of optical coherence tomography-guided FIREHAWK® stent implantation compared with angiography-guided in patients with acute coronary syndrome Clinical Trial
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0003926
- Lead Sponsor
- Chonnam National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
(1) A patient who is diagnosed with acute coronary syndrome over the age of 19 and is scheduled to have a coronary intervention treatment with a firehawk stent.
(2) A patient who decides to participate in this study voluntarily and agrees in writing to the subject's consent
Exclusion Criteria
(1) Patients who have taboo or hypersensitivity to treatment of anti-platelet
(2) Patients with creatin levels greater than 2.0 mg/dL
(3)Patients with end-stage renal failure, including patients undergoing dialysis
(4) If life expectancy is less than 1 year
(5) A woman who is pregnant or wishes to conceive
(6) Cardiopathic shock or Killip Classification IV patient
(7) Patients with a history of stenting with percutaneous coronary intervention
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of failure of target lesions (combination of cardiac death, target vascular myocardial infarction, and ischemia - induced target lesion reconstruction)
- Secondary Outcome Measures
Name Time Method Incidence of myocardial infarction after PCI;Complication rate after PCI;time of procedure;Total Contrast Agents;Total radiation dose